NCT04052061View on ClinicalTrials.gov

QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma

PHASE1WithdrawnINTERVENTIONAL

0

Timeline

Start Date

September 16, 2019

Primary Completion Date

September 18, 2021

Study Completion Date

August 19, 2022

Conditions

Diffuse Large B Cell LymphomaLarge-cell LymphomaLymphoma, B-CellLymphoma

Interventions

BIOLOGICAL

CD19 t-haNK

CD19 t-haNK Suspension for Infusion

Trial Locations (1)

90245

Chan Soon-Shiong Institute for Medicine, El Segundo

Sponsors

Lead Sponsor

ImmunityBio, Inc.

All Listed Sponsors

lead

ImmunityBio, Inc.

INDUSTRY